Evercore ISI Group has upgraded Henry Schein Inc (HSIC) to Outperform from In-Line as of August 25, 2025. The current share price stands at $73.63.
This upgrade underscores a more optimistic outlook on the company's performance, potentially signaling improved fundamentals or stronger business results. Henry Schein, headquartered in Melville, New York, provides healthcare products and services to medical, dental, and veterinary practitioners. The company operates in various segments, including Global Distribution and Value-Added Services, Global Specialty Services, and Global Technology, employing approximately 25,000 full-time staff.
With a market capitalization of $8.4 billion and a price-to-earnings (P/E) ratio of 21.54, Henry Schein is positioned within the competitive healthcare industry. The company is set to announce its next earnings on August 3, 2026, with analysts estimating earnings per share (EPS) of $1.24 on revenue of $3.4 billion.
The recent upgrade reflects a shift in analyst sentiment, which can be influenced by various factors, including the company’s strategic direction and market performance. As of November 1, 2025, the analyst consensus on Henry Schein remains a Hold, with a mix of ratings from Strong Buy to Strong Sell across 23 analysts.
Analyst ratings provide valuable insights but should be considered alongside other factors such as company fundamentals and market trends when making investment decisions. Ratings may change as new information emerges, highlighting the dynamic nature of market evaluations.